TY - JOUR
T1 - The risk and prevention of tuberculosa
T2 - Screening strategies to detect latent tuberculosis among rheumatoid arthritis patients who use biologic therapy
AU - Winthrop, Kevin L.
PY - 2010
Y1 - 2010
N2 - It has become clear in recent years that rheumatoid arthritis (RA) patients are at an increased risk for tuberculosis, primarily due to the immunosuppressive therapies used to treat RA. Since the advent of anti-tumor necrosis factor therapy, the need to screen RA patients for latent tuberculosis infection has heightened, and rheumatologists must stay abreast of changes in diagnostic testing and screening algorithms for tuberculosis. However, these algorithms are a "moving target" as interferon-y-release assays have been recently developed and offer an alternative, or adjunct, to the tuberculin skin test. This article reviews the latest developments in screening methodologies for latent tuberculosis uifection, the strengths and weaknesses of various screening algorithms, as well as other preventive and therapeutic considerations for tuberculosis associated with RA and biological therapies.
AB - It has become clear in recent years that rheumatoid arthritis (RA) patients are at an increased risk for tuberculosis, primarily due to the immunosuppressive therapies used to treat RA. Since the advent of anti-tumor necrosis factor therapy, the need to screen RA patients for latent tuberculosis infection has heightened, and rheumatologists must stay abreast of changes in diagnostic testing and screening algorithms for tuberculosis. However, these algorithms are a "moving target" as interferon-y-release assays have been recently developed and offer an alternative, or adjunct, to the tuberculin skin test. This article reviews the latest developments in screening methodologies for latent tuberculosis uifection, the strengths and weaknesses of various screening algorithms, as well as other preventive and therapeutic considerations for tuberculosis associated with RA and biological therapies.
UR - http://www.scopus.com/inward/record.url?scp=79958850753&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79958850753&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:79958850753
SN - 1478-856X
VL - 8
SP - 43
EP - 52
JO - International Journal of Advances in Rheumatology
JF - International Journal of Advances in Rheumatology
IS - 2
ER -